Objective: We investigate the joint observation between type 2 diabetes and headache using a case--control study of a US ambulatory dataset.
Introduction
Headache, including tension--type headaches, migraine and medication overuse headaches, is the most common neurological disorder 1 . The percentage of the adult population with an active headache disorder is as much as 47 % for a headache in general, 10 % for migraine, 38% for tension--type headache, and 3 % for chronic headache 2 . With the World Health
Organization ranking migraine among the top causes of years of healthy life lost to disability 3 , there is an unmet medical need for therapeutic intervention. However, our understanding of what causes a headache and the association between specific comorbidities and headache prevalence remains unclear.
The positively--correlated association between hypertension disorders 4--8 and psychiatric disorders 9--13 , such as depression and anxiety, has been long established in the literature. Other co--morbidities influencing headache incidence or severity have been reported although the evidence for association with headache has been less robust. Diabetes for example has been suggested to have a protective effect 14--17 although whether the association between headache and type 2 diabetes remains unclear and whether reported effects are due to overlapping molecular mechanisms or to off--target pharmacological effects of diabetes treatment is equally unknown. A possible role for the insulin receptor in migraine pathogenesis was suggested after five significant single nucleotide polymorphism (SNP)
variations were found over--represented in the insulin receptor gene in migraine patients. This association was independently replicated in a case--control population collected separately 14 .
Other related observations include higher insulin levels, a condition associated with prediabetes, in migraineurs than in controls and elevated blood--glucose levels in patients with typical headache 15 . Furthermore, population--based prospective studies have yielded a significant association between a decreased risk of migraine with type 2 diabetes 16, 17 .
Nonetheless, a number of published studies have not reported an apparent protective effect of diabetes. A case--control study examining insulin resistance in migraineurs did not find a significant association with migraine, although the results remained inconclusive given the small sample population and due to several patients with a low disease activity 18 . A cross--sectional study on chronic migraine prevalence in women suggests that chronic migraine is actually positively associated with insulin resistance, particularly when in partnership with obesity 19 . Yet, a different study on the prevalence of migraine in patients with type 2 diabetes failed to find a positive association 20 . Finally, although a recent cross--sectional population--based study also failed to identify an inverse relationship between type 2 diabetes and headache, an association between type 1 diabetes and both headache (OR = 0.55, 95% CI 0.34--0.88) and migraine (OR = 0.47, 95 % CI 0.26--0.96) was found 21 .
Several abnormalities associated with insulin resistance have been reported in patients with migraine 22 . Glucose plasma concentrations were significantly higher in migraineurs with insulin sensitivity impaired in migraine 22 . Studies suggest that insulin resistance is associated with migraine 22 and insulin resistance is also associated with type 2 diabetes 23 . Patients with migraine frequently report that fasting, a condition where there is an insulin receptor activation, is a trigger of headache attacks 24 whilst a separate study revealed that a low--sucrose diet may reduce the frequency of migraine attacks 25 . Clearly, the relationship between headache and type 2 diabetes remains unresolved.
We sought to investigate the joint observation between type 2 diabetes and headache using a case--control study exploiting a large US ambulatory electronic health record (EHR) dataset containing over 6.5 million records. The ICD--9 indication codes presented in the dataset were grouped by the tested comorbidity indications, headache, type 2 diabetes, anxiety and hypertension. To validate our method, we also examined the well--studied relationships between headache with hypertension and headache with anxiety.
Methods

Data source:
We calculate the odds ratio of a joint observation between headache and specific comorbidities using data from The US National Ambulatory Medical Care Survey defined by the ICD--9 code group 300.*, and collectively referred to as anxiety disorders for the purpose of this study. We defined a hypertension indication as any records from the study population with an ICD--9 code from the group 401.*; these codes include malignant essential hypertension, benign essential hypertension and unspecified essential hypertension. 
Results
Identification of diseases.
Disease indications were grouped by their ICD--9 codes (Table 1) . Headache codes were collected using the classification for a tension headache and general diagnosis for headache.
Instances of cluster headache were excluded due to their infrequency within the sampled population. The grouped anxiety indications were collected using the ICD--9 tree from EHRs that matched the regular expression 300.*. These codes included indication for anxiety, phobias, dissociative disorders and somatization disorders. The grouped hypertension indications were matched using the regular expression 401.*. Only three hypertension ICD--9 codes, malignant, benign and unspecified, were present. The ICD--9 codes for type 2 diabetes were picked specifically to include indications for type 2 diabetes without a mention of further complication.
Disease prevalence and demographic data. In this study, we identified 3,327,947 EHRs that met our inclusion criteria, of which 1,130,505 were male and 2,197,442 were female. A t--test performed between the age of males to females was found to be insignificant ( All estimated ORs were statistically significant (p < 0.01).
Conclusions
This case--control study of a large US EHR dataset presents results that suggest type 2 diabetes has a protective association on headache prevalence in male and female cohorts between 18
and 65 years of age. Our findings of a joint observation between headache and hypertension and anxiety disorders demonstrates that this dataset is in agreement with existing literature, validating our methodology. Earlier accounts of an association between diabetes and headache have been reported 14--25 , however, we present a new case--control study using an ambulatory survey curated with over thirty years of patient cases across an extensive and diverse population.
This study takes no account for some of the confounds or other concerns of conventional epidemiology. Specifically; there are fewer indications per record during the first surveyed year (1979), suggesting potential unclassified cases; it is not possible to be sure whether the observed tested co--morbidity (anxiety, hypertension, type 2 diabetes) is due to the disease itself or any prescribed medications; statistical analysis over explicit indication for migraine does not have statistical power; and, finally, there exists outdated diagnoses for vascular headache, which is considered as an outdated term and a misdiagnosis. Despite the limitations of deriving knowledge from data using this approach, the fact that our findings for the odds ratio of observing headache with an indication for either anxiety of hypertension replicate earlier studies offers strong support to our results. Further population based studies taking into account prescribed medications would be the first step in separating physiological effect from pharmacological effect. Insights into the etiological overlap between headache and type 2 diabetes might be revealed from common genetic associations between the two disorders within large, well phenotyped and genotyped cohorts such as the UK Biobank. Panic disorder, with agoraphobia 300. 10 Hysteria, unspecified 300.11
Funding
Conversion disorder 300. 12 Dissociative amnesia 300. 15 Dissociative disorder or reaction, unspecified 300. 16 Factitious disorder with predominantly psychological signs and symptoms 300. 20 Phobia, unspecified 300.29
Other isolated or specific disorders 300.3
Obsessive--compulsive disorders 300. 4 Dysthymic disorder 300.5 Neurasthenia 300. 7 Hypochondriasis 300.81
Somatization disorder 300.89
Other somatoform disorders 300. 9 Unspecified nonpsychotic mental disorder 300.02
Generalized anxiety disorder 300. 13 Dissociative fugue 300.14 Dissociative identity disorder 300. 21 Agoraphobia with panic disorder 300.09
Other anxiety states 300. 22 Agoraphobia without mention of panic attack 300. 6 Depersonalization disorder 300. 19 Other and unspecified factitious illness 300. 23 Social Table 3 . The OR (95% CI) of each disorder in association with a headache indication, over the whole population matched for age and gender, and then matched for age and stratified by gender. ** p < 0.001 and * p < 0.01
